<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00164970</url>
  </required_header>
  <id_info>
    <org_study_id>RCT-B12</org_study_id>
    <nct_id>NCT00164970</nct_id>
  </id_info>
  <brief_title>Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?</brief_title>
  <official_title>Can Oral Vitamin B12 and Folate Supplementation Preserve Cognitive Function of Patients With Early Dementia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <brief_summary>
    <textblock>
      Background: Vitamin B12 and folate are essential to brain health. Sub optimal status of
      vitamin B12 and folate leads to elevation of plasma homocysteine concentration, which is
      associated with Dementia. Vitamin B12 and folate supplementation improved the cognitive
      function of demented subjects with hyperhomocysteinaemia in a pilot study.

      Objective: To determine the effectiveness of vitamin B12 and folate supplementation in
      preserving cognitive function of subjects with early dementia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After stratified randomization by mini mental state examination scores, supplement group
      subjects take 1 mg of methylcobalamin and 5 mg of folic acid daily, while placebo group
      subjects take placebo capsules. The primary outcome is Mattis dementia rating scale. The
      secondary outcomes are mini mental state examination, neuropsychiatric inventory, and Cornell
      scale for depression in dementia. These measurements will be performed at baseline and every
      six months for 24 months. Fasting plasma homocysteine concentrations are measured at baseline
      and 18-month follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>dementia rating scale</measure>
    <time_frame>at 6 months, 12 months and 18 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>depression rating scale</measure>
    <time_frame>at 6 months, 12 months and 18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>vitamin b12</measure>
    <time_frame>at 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>folate</measure>
    <time_frame>at 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>homocysteine</measure>
    <time_frame>at 18 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">166</enrollment>
  <condition>Dementia</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin B12</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>folate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dementia of Alzheimer's or vascular type

          -  Early dementia defined by Clinical Dementia Rating of 1.

        Exclusion Criteria:

          -  lives alone

          -  significant communication problems

          -  significant co-existing diseases

          -  blood tests:vitamin B12&lt; 150 pmol/l, serum creatinine&gt; 250 mol/l, hypothyroidism and
             syphilis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy CY Kwok, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <state>Hong Kong</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2005</study_first_posted>
  <last_update_submitted>February 2, 2009</last_update_submitted>
  <last_update_submitted_qc>February 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2009</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 12</mesh_term>
    <mesh_term>Hydroxocobalamin</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

